https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52348 Wed 28 Feb 2024 15:40:27 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36948 Wed 19 Jan 2022 15:16:10 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48575 P = 2/55; confidence interval = 0.44-12.53%). The cost comparison suggests the cost implementation of cCMV screening (and subsequent potential treatment benefits and management over time), compared to non-screening (and subsequent management), to be negligible. Conclusion: Incorporating cCMV testing into Universal Newborn Hearing Screening within Queensland is realistic and achievable, both practically and financially.]]> Tue 21 Mar 2023 16:55:10 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54220 65 years of age, 36 (8%) were children (< 16 years), 6 (1%) were Aboriginal and Torres Strait Islander peoples, 4 (1%) were pregnant and 289 (65%) had chronic comorbidities. COVID-19 hospital admissions peaked between weeks 13 and 15 (first wave) nationally, and again between weeks 31 and 35 (Victoria), with most admissions represented by those above 40 years of age. Discussion: There was an unusually low number of hospital admissions with laboratory-confirmed influenza in this season, compared to recent seasons. This is likely to be due to effective public health interventions and international border closures as a result of a rise in COVID-19 respiratory infections and associated hospitalisations.]]> Tue 13 Feb 2024 12:02:47 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52205 Thu 05 Oct 2023 10:15:34 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48191 Sat 11 Mar 2023 12:30:28 AEDT ]]>